Conversation with The Cancer Letter Charles Sawyers: Project GENIE demonstrates what a coalition of willing institutions is able to do August 04, 2017Vol.43 No.31By Matthew Bin Han Ong
Conversation with The Cancer LetterFree Rita Redberg: FDA proposal to delay reporting of device malfunctions “should be tossed” July 28, 2017Vol.43 No.30By Matthew Bin Han Ong
Conversation with The Cancer Letter Will Parsons: This is a fantastic opportunity to test precision oncology for pediatric patients in a large-scale way July 28, 2017Vol.43 No.30By Paul Goldberg
Conversation with The Cancer LetterFree Klausner: CRUK Grand Challenge—more than just another grant July 21, 2017Vol.43 No.29By Paul Goldberg
Conversation with The Cancer LetterFree Keith Flaherty: We will certainly stop if we enroll all subprotocols July 07, 2017Vol.43 No.27By Paul Goldberg
Conversation with The Cancer LetterFree Barbara Conley: Learning from first broad foray into precision medicine July 07, 2017Vol.43 No.27By Paul Goldberg
Conversation with The Cancer Letter Michael Birrer named director of the University of Alabama at Birmingham Comprehensive Cancer Center June 09, 2017Vol.43 No.23By Paul Goldberg
Conversation with The Cancer Letter Maria Koehler: Real-world data is “truly a revolution” June 09, 2017Vol.43 No.23By Matthew Bin Han Ong
Conversation with The Cancer LetterFree A nascent group of academics plans to conduct randomized trials to determine value of care June 02, 2017Vol.43 No.22By Paul Goldberg
Conversation with The Cancer Letter Cary Gross: We need to learn to analyze real-world evidence rigorously June 02, 2017Vol.43 No.22By Matthew Bin Han Ong
